Updates are available Correction dated 2025-05-22
Click to view Correction: https://doi.org/10.1038/s41586-025-09124-6
-
Authors
Zhuang, Xueqian https://orcid.org/0000-0001-7012-3223
Wang, Qing
Joost, Simon
Ferrena, Alexander https://orcid.org/0000-0002-9578-8683
Humphreys, David T. https://orcid.org/0000-0003-4140-0089
Li, Zhuxuan
Blum, Melissa https://orcid.org/0000-0001-5372-9004
Krause, Klavdija
Ding, Selena
Landais, Yuna
Zhan, Yingqian https://orcid.org/0000-0002-3548-9227
Zhao, Yang https://orcid.org/0000-0002-8216-6420
Chaligne, Ronan https://orcid.org/0000-0003-4332-3291
Lee, Joo-Hyeon https://orcid.org/0000-0002-7364-6422
Carrasco, Sebastian E. https://orcid.org/0000-0002-1926-7296
Bhanot, Umeshkumar K. https://orcid.org/0000-0001-6656-1239
Koche, Richard P. https://orcid.org/0000-0002-6820-5083
Bott, Matthew J. https://orcid.org/0000-0003-0523-4028
Katajisto, Pekka https://orcid.org/0000-0002-3033-4189
Soto-Feliciano, Yadira M.
Pisanic, Thomas https://orcid.org/0000-0001-5796-0836
Thomas, Tiffany
Zheng, Deyou https://orcid.org/0000-0003-4354-5337
Wong, Emily S. https://orcid.org/0000-0003-0315-2942
Tammela, Tuomas https://orcid.org/0000-0003-3675-6961
- License Information
-
More Information
Article History
Received: 23 December 2022
Accepted: 24 October 2024
First Online: 4 December 2024
Change Date: 22 May 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41586-025-09124-6
Competing interests
: T. Tammela is a scientific advisor with equity interests in Lime Therapeutics. His spouse is an employee of and has equity in Recursion Pharmaceuticals. The Tammela Laboratory receives funding from Ono Pharma unrelated to this work. E.S.W. has equity in and her spouse is a co-founder of and equity holder in Gertrude Biomedical Pty. The other authors declare no competing interests.
